Robert H Shoemaker

USPTO Granted Patents = 11 (Patent Applications = 1)

CIPO Patents = 1 (Patent Applications = 1)

EPO Patents = 2 (Patent Applications = 1)

Average Co-Inventor Count = 4.5

ph-index = 3

Forward Citations = 47(Granted Patents)

Location History:

No. Potomac, MD (US) (1998)
Potomac, MD (US) (2001)
Frederick, MD (US) (1998 - 2006)
Boyds, MD (US) (2009 - 2021)

Company Filing History:

7 out of 3,435

National Institutes of Health, a Component of the US Dept. of Health & Human Services

patents

2 out of 16,070

USA As Represented by Secretary of the Navy

patents

2 out of 1,215

The United States of America As Represented by the Department of Health

Provid Pharmaceuticals Inc.

patents

where one patent can have more than one assignee

Years Active: 1998-2021

Loading Chart...

11 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 10913709 - STAT3 inhibitor formulation (2021-02-09),

2. 9278089 - Method of treating HCV infection with a small molecule CHK2 inhibitor (2016-03-08),

3. 8912214 - Use of Chk2 kinase inhibitors for cancer treatment (2014-12-16),

4. 8765802 - Kinase inhibitors, compositions thereof, and methods of use therewith (2014-07-01),

5. 7572828 - Identification of anti-HIV compounds inhibiting virus assembly and binding of nucleocapsid protein to nucleic acid (2009-08-11),

6. 6987096 - Antiviral proteins and peptides, DNA coding sequences therefor, and uses thereof (2006-01-17),

7. 6245737 - Conjugates of antiviral proteins or peptides and virus or viral envelope glycoproteins (2001-06-12),

8. 5998587 - Anti-cyanovirin antibody (1999-12-07),

9. 5962668 - Nucleic acids encoding antiviral proteins and peptides fused to effector (1999-10-05),

10. 5843882 - Antiviral proteins and peptides (1998-12-01),

11. 5821081 - Nucleic acids encoding antiviral proteins and peptides, vectors and host (1998-10-13),

Title: The Innovations of Robert H. Shoemaker

Introduction

Robert H. Shoemaker is a notable inventor based in Boyds, MD (US), recognized for his significant contributions to the field of pharmaceuticals. With a total of 11 patents to his name, he has made strides in developing innovative treatments for various medical conditions, particularly in cancer and viral infections.

Latest Patents

Among his latest patents is a formulation for a STAT3 inhibitor. This invention discloses a salt prepared from the STAT3 inhibitor known as 2-hydroxy-4-[[2-[[(4-methylphenyl)sulfonyl]oxy]acetyl]amino] benzoic acid and 2-amino-2-(hydroxymethyl)-1,3-propanediol. The salt is notable for its solubility in water and stability over extended periods. Additionally, he has developed a method for treating Hepatitis C Virus (HCV) infection using a small molecule CHK2 inhibitor. This method involves providing a therapeutically effective amount of a compound to patients in need, showcasing his commitment to advancing medical treatments.

Career Highlights

Robert H. Shoemaker has had a distinguished career, working with prestigious organizations such as the National Institutes of Health, a component of the US Department of Health & Human Services, and the United States Navy. His work in these institutions has allowed him to contribute to significant advancements in medical research and pharmaceutical development.

Collaborations

Throughout his career, Shoemaker has collaborated with esteemed colleagues, including Michael R. Boyd and Kirk R. Gustafson. These partnerships have fostered an environment of innovation and have led to the successful development of his patented inventions.

Conclusion

Robert H. Shoemaker's contributions to the field of pharmaceuticals through his innovative patents and collaborations highlight his dedication to improving healthcare. His work continues to impact the treatment of serious medical conditions, making him a significant figure in the realm of medical inventions.

This text is generated by artificial intelligence and may not be accurate.